The Challenge

An animal health company sought to commercialize a new product without undergoing formal USDA or FDA approval. To achieve this, they needed to demonstrate that their product fell outside of specific agency jurisdictions while remaining compliant with all labeling regulations. During the engagement, a late-stage shift in the intended user necessitated significant updates to the product’s intended environment positioning and labeling, complicating the path to a non-jurisdictional consensus.

The Solution

Our team performed a comprehensive technical and regulatory review to refine the client’s formal submission. We transformed the initial correspondence into a robust, scientifically grounded justification that explicitly referenced applicable regulations and strengthened their position. To address the change in the intended user, we developed several product labeling documents and built a persuasive narrative for the new intended use and user environment, ensuring the documentation remained cohesive and defensible.

The Outcome

By providing a rigorous justification for the product’s status, we equipped the client with a strong regulatory package for agency presentation. This high-quality documentation provides the company with the necessary clarity to execute a strategic go-to-market launch. While final agency concurrence is pending, our work has significantly increased the likelihood of a favorable outcome and established a defensible framework for the client’s commercial operations.